The selective vasopressin 2 receptor antagonist Tolvaptan at a moderate dose is effective and safe in treatment of Hyponatremia following pituitary surgery

Andrea Kleindienst, Sven-Martin Schlaffer, Marc Andre Schwarz, Irene Emtmann, Ferdinand Swozil & Michael Buchfelder
Objective: Hyponatremia is frequently encountered in patients with intracranial processes, and contributes substantially to the related morbidity and mortality. The pathophysiology of hyponatremia is not completely understood, and may in part be explained by the syndrome of inappropriate secretion of[for full text, please go to the a.m. URL]